Albert Luderer - 18 Jun 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Director
Signature: /s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 18 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Jun 2024, 16:23:15 UTC
Previous filing: 16 Jun 2023
Next filing: 12 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	18 Jun 2024	Common Stock	30,000	$0.7752	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

Content

The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).